Previous Article | Next Article 
Journal of Clinical Microbiology, January 2000, p. 227-235, Vol. 38, No. 1
0095-1137/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Typing of Candida glabrata in Clinical
Isolates by Comparative Sequence Analysis of the Cytochrome
c Oxidase Subunit 2 Gene Distinguishes Two Clusters of
Strains Associated with Geographical Sequence Polymorphisms
Gerdine F. O.
Sanson and
Marcelo R. S.
Briones*
Departamento de Microbiologia, Imunologia e
Parasitologia, Escola Paulista de Medicina, Universidade Federal de
São Paulo, São Paulo S.P. 04023-062, Brazil
Received 19 July 1999/Returned for modification 27 August
1999/Accepted 1 October 1999
 |
ABSTRACT |
We tested whether comparative sequence analysis of the
mitochondrion-encoded cytochrome c oxidase subunit 2 gene
(COX2) could be used to distinguish intraspecific variants
of Candida glabrata. Mitochondrial genes are suitable for
investigation of close phylogenetic relationships because they evolve
much faster than nuclear genes, which in general exhibit very limited
intraspecific variation. For this survey we used 11 clinical isolates
of C. glabrata from three different geographical locations
in Brazil, 10 isolates from one location in the United States, 1 American Type Culture Collection strain as an internal control, and the
published sequence of strain CBS 138. The complete coding region of
COX2 was amplified from total cellular DNA, and both
strands were sequenced twice for each strain. These sequences were
aligned with published sequences from other fungi, and the numbers of
substitutions and phylogenetic relationships were determined. Typing of
these strains was done by using 17 substitutions, with 8 being
nonsynonymous and 9 being synonymous. Also, cDNAs made from purified
mitochondrial polyadenylated RNA were sequenced to confirm that our
sequences correspond to the expressed copies and not nuclear
pseudogenes and that a frameshift mutation exists in the 3' end of the
coding region (position 673) relative to the Saccharomyces
cerevisiae sequence and the previously published C. glabrata sequence. We estimated the average evolutionary rate of
COX2 to be 11.4% sequence divergence/108 years
and that phylogenetic relationships of yeasts based on these sequences
are consistent with rRNA sequence data. Our analysis of
COX2 sequences enables typing of C. glabrata
strains based on 13 haplotypes and suggests that positions 51 and 519 indicate a geographical polymorphism that discriminates strains
isolated in the United States and strains isolated in Brazil. This
provides for the first time a means of typing of Candida
strains that cause infections by use of direct sequence comparisons and
the associated divergence estimates.
 |
INTRODUCTION |
The incidence of infections caused
by non-Candida albicans Candida species is steadily
increasing in AIDS and cancer patients (10, 14). Among these
non-C. albicans species that cause infections, Candida
glabrata is important because it is primarily resistant to
fluconazole and therefore has recently been the focus of intensive research (15, 24, 25). The epidemiology of C. glabrata infections needs to be studied by obtaining measurements
of the genotypic variation because intraspecific phenotypic
differentiation is negligible. Although typing of C. glabrata intraspecific variants can be done by randomly amplified
polymorphic DNA (RAPD) analysis, restriction fragment length
polymorphism (RFLP) analysis, and molecular karyotyping, it is
challenging to find adequate primers, sites, and probes that will
enable discrimination of these closely related isolates (18,
26). Also, most differences in band patterns are difficult to
interpret because band intensity and reproducibility are not absolutely
consistent (23, 26). Direct comparison of DNA sequences is
preferable for typing of these pathogenic yeasts because methods based
on comparison of patterns (e.g., RAPD analysis, RFLP analysis,
pulsed-field gel electrophoresis, and multilocus isozyme analysis) are
indirect measurements of genetic divergence and can be affected by
paralogy and nonindependence of characters (31). Differences
in band patterns are much more difficult to analyze under probabilistic
models of divergence, which are routinely used for direct sequence
comparisons, such as substitution matrices used in maximum likelihood
analysis (31). This limitation is due to the difficulty in
attributing state-transition probabilities of pattern data as opposed
to nucleotide data. The probabilistic approach is required to put the
epidemiological transmission framework into a divergence-time
perspective, because divergence times can be estimated from phylogenies
inferred from DNA sequences. Accordingly, to build the phylogeny that
reconstructs the path of orthologous steps that led to the observed
divergence, the observed substitutions must be corrected by
probabilistic models because of reverse, parallel, and convergent
substitutions (17). Comparative analysis of molecular
sequences has been used for a variety of taxonomic groups to determine
relatedness (34). The rRNA subunit genes have extensively
been used as macroevolutionary markers of microorganism phylogeny and
taxonomy, including those of pathogenic yeasts, because of functional
equivalence, size, and universal distribution (1, 33).
However, intraspecific sequence comparisons of nuclear genes in
eukaryotes, especially in those genes for which divergence was very
recent or the evolutionary rate is very small, exhibit few or no
substitutions which preclude the use of such sequences for typing.
Mitochondrion-encoded genes evolve approximately 10-fold faster than
nuclear genes due to low-fidelity replication, defective repair, and
high concentrations of mutagens in mitochondria and therefore are more
suitable for use for the resolution of close phylogenetic relationships
(2, 3).
Here we tested whether sequences of the mitochondrion-encoded
cytochrome c oxidase subunit 2 gene (COX2) could
be used to discriminate intraspecific variants of the pathogenic yeast
C. glabrata. We typed 23 different strains by comparison of
COX2 sequences and found 13 haplotypes. Our data enabled the
differentiation of clinical variants on the basis of 2.1% variant
positions of 756 positions compared and suggest that at least two
positions contain synonymous substitutions that reflect regional differences.
 |
MATERIALS AND METHODS |
Clinical isolates.
All Brazilian strains were obtained from
the fungus collection of the Laboratório Especial de Micologia
(LEMI), Disciplina de Doenças Infecciosas e Parasitárias
(DIPA), Departamento de Medicina, Universidade Federal de São
Paulo, and were collected from cancer, diabetes, and intensive care
unit patients (abdominal surgery) (labeled C, D, and I in Table
1) from 29 December 1994 to 28 May 1997. Isolates from the United States were provided by David Perlin, Public
Health Research Institute, New York University. The U.S. isolates were
obtained from cancer patients at the Memorial Sloan Kettering Cancer
Center in New York City over a 6-month period from 1 July 1998 to 31 December 1998 (Table 1).
Isolation of total DNA and mtRNA.
Total genomic DNA was
isolated by the fast miniprep protocol as described previously
(32). Mitochondrial RNA (mtRNA) was isolated by a
modification of the method described by Defontaine and collaborators
(6). Briefly, yeasts were grown in YPD (1% yeast extract,
2% peptone, 2% dextrose) overnight at 30°C and were harvested by
centrifugation at 500 × g for 5 min. Pellets were
washed twice with water and once with SEM (1.2 M sorbitol, 50 mM EDTA,
2% mercaptoethanol), resuspended in 5 ml of Sol A (0.5 M Sorbitol, 10 mM EDTA, 50 mM Tris [pH 7.5]) containing 2% mercaptoethanol and 0.2 µg of Zymolyase 20T (ICN) per ml, and incubated at 37°C for 45 min
with gentle agitation to digest the cell walls. The resulting
spheroplast suspension was sonicated at 19 kHz with pulses of 300 ms/s
for 1 min. The lysate was centrifuged at 1,000 × g for
10 min and the supernatant containing the mitochondria was centrifuged
at 15,000 × g for 15 min. After the crude
mitochondrial pellet was washed four times with Sol A it was
resuspended in 1 ml of Trizol (GIBCO) and vortexed, and 200 µl of
chloroform was added. After incubation for 2 min at room temperature
the suspension was centrifuged at 12,000 × g at 4°C
for 15 min. After precipitation with 500 µl of isopropanol and
washing with 70% ethanol, the mtRNA was resuspended in 40 µl diethyl
pyrocarbonate (DEPC)-treated water and quantitated by spectrophotometry
as described previously (29).
Amplification (PCR) and sequencing.
The complete coding
region of COX2 was amplified in 50 µl of the PCR mixture
with Taq DNA polymerase buffer (50 mM KCl, 1.5 mM
MgCl2, 10 mM Tris-HCl [pH 9.0]), 0.4 mM deoxynucleoside
triphosphates, 2 mM MgCl2, 120 pmol of each primer, 1.5 U
of Taq DNA polymerase (Pharmacia), and 1.5 µg of total
cellular DNA. Cycling conditions were 94°C for 7 min and 45 cycles of
94°C for 1 min, 42°C for 1 min, and 72°C for 1 min, followed by a
final extension at 72°C for 7 min in a Perkin-Elmer 9600 thermocycler.
COX2 cDNAs were obtained by reverse transcription (RT)-PCRs.
For RT reactions, 2 µg of total mtRNA was incubated with 500
pg of
oligo(dT)
12-18 (GIBCO) in a 10-µl mixture, and the
mixture was incubated for 4 min at 98°C. After cooling on ice,
4 µl
of first-strand buffer (250 mM Tris-HCl [pH 8.3], 375 mM
KCl, 15 mM
MgCl
2), 2 µl of 0.1 M dithiothreitol, 1 µl of 10 mM
deoxynucleoside triphosphates, and 3 µl of DEPC-treated water
were
added to this mixture. The mixture was incubated for 2 min
at 42°C,
and then 1 µl (200 U) of Superscript II reverse transcriptase
(GIBCO)
was added and the reaction mixture was incubated at 42°C
for 1 h
and then at 70°C for 15 min. For amplification, 1 µl of
the RT
reaction mixture was used in a standard
COX2 PCR as
described
above. Amplification of actin cDNA was used as a positive
control
whenever required. For actin cDNA amplification, primers act1F
(5'-AGAATTGATTTGGCTGGTAGAGAC-3') and act1R
(5'-AGAAGATGGAGCCAAAGCAGTAAT-3')
were used. These were
designed from the published sequence (GenBank
accession no.
X16377) and
amplify a 443-bp fragment encompassing
positions 2213 to 2656 of the
Candida act1 gene. Amplification
reaction conditions were as
described above, except that annealing
was at 50°C for the act1F and
act1R
primers.
The amplified fragments were visualized after separation by agarose gel
electrophoresis with ethidium bromide (0.5 µg/ml)
staining. PCR
amplicons were cloned into pBluescript II SK (Stratagene)
by T-A
cloning (
22) after preparative agarose gel electrophoresis
and purification in Spin-X centrifuge filters (Costar). Cloned
COX2 amplicons were sequenced by the dideoxynucleotide chain
termination
method of Sanger et al. (
30) but modified for
cycle sequencing
and fluorescent "Big-Dye" terminators
(Perkin-Elmer) in an ABI
PRISM 377/36 automated sequencer according to
the manufacturer's
instructions.
Comparative sequence analysis and phylogenetic inference.
The sequences of both strands from each cloned amplicon were obtained
in duplicate from different PCRs and were assembled into single contigs
corresponding to each individual strain by using SeqMan from
Lasergene-DNASTAR package (DNASTAR Inc., Madison, Wis.). Alignments
were done by using the Clustal algorithm in the DNASTAR package
(MegAlign) (16), and manual corrections were done by using
the Seaview sequence editor for UNIX (12). Phylogenetic
analysis was done by using Phylo_Win for UNIX by using the maximum
likelihood and neighbor-joining algorithms (9, 12, 27). The
substitution model used was F84 with transversion/transition ratios of
2.0 and 1.13, as inferred from the data. Bootstrap analysis (8) was done with 500 replications by using Phylo_Win. The small-subunit rRNA sequences were downloaded from GenBank and were
aligned by using as a guide the general alignment of the Ribosomal
Database Project (http://www.cme.msu.edu/rdp/) (21).
Small-subunit rRNA gene sequences from the following species were used
(GenBank accession numbers are given in parentheses):
Bretanomyces anomalus NCYC 749 (
X83816),
Bretanomyces
bruxellensis NCYC 362 (
X83814),
Candida glabrata CBS138
(
X51831),
Candida glabrata ATCC 2001 (
M60311),
Dekkera
bruxellensis (
X58052),
Dekkera custersiana CBS 4805 (
X83817),
Dekkera naardenensis (
X85110),
Kluyveromyces
thermotolerans (
X89526),
Pichia anomala M8 (
D86914),
Saccharomyces cerevisiae (
Z75578),
Saccharomyces
exiguus (
X98868),
Schizosaccharomyces pombe (
X58056),
and
Williopsis saturnus strain CBS 6342 (
Y12112).
Cytochrome oxidase subunit 2 sequences from the following species were
used (GenBank accession numbers are given in parentheses):
Saccharomyces cerevisiae V00706 (
J01482),
Saccharomyces exiguus (
X69429),
Williopsis
saturnus var.
suaveolens (
X73415),
Williopsis
saturnus var.
makrii (
X66595),
Dekkera
bruxellensis (
X64823),
Kluyveromyces lactis
(
X15999-13025),
Kluyveromyces thermotolerans (
X69431),
Pichia jadinii (
X73414-404320),
C. glabrata
(
X69430),
Brettanomyces custersii (
X64824),
Brettanomyces nanus (
X64825),
Brettanomyces
naardenensis (
X64821),
Brettanomyces custersianus
(
X64826),
Brettanomyces anomalus (
X64822),
Neurospora
crassa (
K00825),
Emericella nidulans (
X15441-12716),
Schizosaccharomyces pombe (
X54421-13639),
Reclinomonas americana (
AF007261), and
Thiobacillus ferrooxidans (
AJ006456-3282056).
 |
RESULTS |
COX2 primer design and amplification.
The C. glabrata COX2-specific primers COF
(5'-ATGTTAAATTTATTATATAA-3') and COR
(5'-TTATTGTTCGTTTAATCATTC-3') were designed to amplify the
entire coding region, and their sequences were determined from the
published sequence (GenBank accession no. X69430) (4). For
all 10 C. glabrata strains the 750-bp fragment was amplified
from total cellular DNA (Fig. 1). Also,
as expected, these primers did not amplify S. cerevisiae
COX2 (Fig. 1A, lane 11) or C. albicans (data not shown)
because of highly divergent sequences in the N terminus of the
COX2 protein, which corresponds to primer COF. Because
nuclear pseudogenes can be coamplified with the expressed mitochondrial
copies, we also amplified COX2 from isolated mtRNA and
converted it to cDNA with oligo(dT) due to polyadenylation of
mitochondrial transcripts (Fig. 1B). As shown in Fig. 1B (lane 5), a
single fragment of 750 bp was amplified from oligo(dT), and no
fragments were amplified from the negative control (Fig. 1B, lane 4),
which consisted of PCR with COF and COR primers from a mock RT reaction
containing no reverse transcriptase. This result shows that the
amplified fragment of 750 bp from oligo(dT) cDNAs was reverse
transcriptase dependent and, therefore, was not derived from
contaminating DNA in the mtRNA preparation.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 1.
PCR and RT-PCR of COX2 genes from total
cellular DNA and mtRNA. (A) COX2 was amplified as a 756-bp
product from total cellular DNAs of 10 strains of C. glabrata (lanes 1 to 10, respectively) but not from S. cerevisiae total cellular DNA (lane 11). C. glabrata
DNA samples correspond to strains 05, 06, 12, 13, 36, 37, 38, 39, 47 and ATCC 90030, respectively (TABLE 1). (B) COX2 was
amplified from purified mtRNA of C. glabrata 06 (Table 1)
(lanes 5 and 7). The cDNAs were synthesized either from oligo(dT)
primers (lane 4) or from the COR primer (lane 7). Negative controls
consisted of mock RT reactions with oligo(dT) (lane 4) or COR primer
(lane 6) lacking reverse transcriptase to demonstrate that the
COX2 product was reverse transcriptase dependent.
Amplification of actin cDNA from oligo(dT) was used to control for RNA
integrity, RT efficiency, and contamination with nonmitochondrial mRNA
(lane 3) with the corresponding mock RT reaction-negative control to
exclude the possibility of DNA contamination (lane 2). Amplification of
COX2 from total cellular DNA was used as a positive control
for PCR (lane 1). The identities of the COX2 and actin cDNA
amplicons were checked by sequencing. Lane M, molecular size markers
(phage lambda DNA cut with HindIII for panel A and a
100-bp ladder [GIBCO BRL] for panel B).
|
|
Intraspecific sequence comparison of COX2.
The amplicons
shown in Fig. 1A (lanes 1 to 10) and Fig. 1B (lane 5) were cloned and
sequenced. Alignment and comparison of these sequences shows that the
COX2 fragments amplified from total cellular DNA correspond
to expressed copies and not nuclear pseudogenes because the sequence of
ATCC 90030 is identical in both mitochondrial cDNA and mitochondrial
DNA (Fig.
2, second
and third sequences in the alignment). A frameshift mutation at
position 673 is present in all sequences, including that of the ATCC
90030 control, except strain CBS 138 and S. cerevisiae. This
frameshift mutant in C. glabrata sequences (C insertion in
position 673) is present in the mRNA, which suggests that frameshift
mutation suppressor mechanisms, such as a suppressor tRNA and RNA
polymerase slippage, might exist in the mitochondria of C. glabrata to yield a functional COX2 peptide.
Substitutions between the different strains are summarized in Fig.
3 and were confirmed by sequencing both
strands in duplicate and from independent PCRs to exclude
Taq DNA polymerase artifacts and heteroplasmic effects.
Also, identical sequences were obtained by direct sequencing of PCR
products.



View larger version (114113110K):
[in this window]
[in a new window]
|
FIG. 2.
Alignment of COX2 sequences from C. glabrata clinical isolates and those from previously published
strain CBS 138 and S. cerevisiae (S.c). Sequence names
correspond to the names in Table 1 (C.g, C. glabrata). The
cDNA sequence (second from top to bottom) was determined from strain
ATCC 90030. The frameshift mutation (C insertion) is located at
position 673. Boxed residues indicate differences from the consensus
sequence.
|
|

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 3.
Summary of alignment of variant positions of C. glabrata COX2. Open boxes indicated the synonymous substitutions,
and underscores indicate the nonsynonymous substitutions. The asterisks
at the bottom indicate the substitutions at positions 51 and 519 that
separate type 1 strains from type 2 strains.
|
|
The summary alignment in Fig.
3 shows 13 haplotypes or alleles of the
COX2 sequences. These were named A through M here. These
13 haplotypes can be further grouped into two types, named 1 and
2. Type 1 strains encompass 9 of 10 isolates from the United States
and type 2 corresponds to 9 of 11 isolates from Brazil. The most
abundant
haplotype among Brazilian isolates is haplotype G (36%),
and the most
abundant haplotype among isolates from the United
States is haplotype B
(60%). Within our sample there are nine
synonymous substitutions and
seven nonsynonymous substitutions,
which are expected in a gene under
negative selective pressure,
such as
COX2. The most
important changes occur at positions 51
and 519. The residue at
position 51 of type 1 strains is G, and
the residue at position 51 of
type 2 strains is A (transition);
while the residue at position 519 of
type 1 strains is A, and
the residue at position 519 of type 2 strains
is T (transversion).
These characters are the central differences
regarding type 1
and type 2
COX2. Because they are
synonymous substitutions and
therefore do not change the amino acid
sequence, they might reflect
the evolutionary histories of these
strains and not adaptative
changes.
Evolutionary analysis of COX2.
Phylogenetic analysis was
used to estimate the rate of evolution of COX2 in yeasts
and, consequently, the divergence times between different species and
isolates. This is important for epidemiological investigations because
it can provide estimates on how likely it is that different patients
have acquired C. glabrata from single or different sources.
The sequences of 18S ribosomal DNA (small-subunit rRNA gene) of five
representative yeast species, K. thermotolerans, K. lactis, S. cerevisiae, S. exiguus, and
C. glabrata, were aligned by using as a guide the general
small-subunit rRNA alignment from the Ribosomal Database Project
(21). The phylogenetic distances were inferred for these
species by using the Kimura-2-parameter model for nucleotide
substitution and the divergence times calculated by using the
expression T = KSSUrRNA/2rSSUrRNA (20) (where T is the divergence time,
KSSUrRNA is the corrected phylogenetic distance
for the small-subunit rRNA genes, and rSSUrRNA is the evolutionary rate of the small-subunit rRNA gene, which is
0.85%/108 years [7]). The evolutionary
rate of COX2 genes in the yeast group
(11.4%/108 years) was estimated by using the alignments of
the COX2 sequences. The phylogenetic distances of
COX2 genes (Kimura-2-parameter model) between K. thermotolerans, K. lactis, S. cerevisiae,
S. exiguus, and C. glabrata were used in the
expression rCOX2 =
KCOX2/2T (where r is the
evolutionary rate, K is the phylogenetic distance, and T is the divergence time estimated from the 18S rRNA
comparisons). Because rCOX2 is 11.4% sequence
divergence/108 years, we estimate that the comparison of
COX2 genes would be able to detect mutations that occurred
at least 570,000 years ago. One mutation in 756 bp represents a
distance of 0.013% sequence divergence, and therefore, use of the
expression T = KCOX2/2rCOX2, with
rCOX2 equal to 11.4%, gives a value of
T of 0.57 × 106 years.
From the
COX2 sequence data set, we estimated whether the
sequence distances of
COX2 might be consistent with
taxonomy. Phylogenetic
distances (percent distances) were plotted
against different taxonomic
ranks and show that a divergence of about
20% is consistent with
genus differences, divergence of 10% is
consistent with species
differences, and divergence of below 1% with
intraspecific variant
differences (Fig.
4). This indicates that the level of
polymorphism
that we detected is in the range expected at the
intraspecific
variant taxonomic level.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 4.
Correlation between percent COX2 sequence
distances and taxonomic distances. Points in the plot indicate the
average distance for the pairwise comparison for a given category, and
error bars indicate the associated standard deviation.
|
|
The
COX2 sequences were also used to infer the phylogeny of
some genera of yeasts and the phylogeny of the different strains
of
C. glabrata (Fig.
5). The
phylogeny in Fig.
5A (ln L =

5374.780)
supports the proximity of
C. glabrata to
S. cerevisiae and puts
into the
perspective of macroevolution the intraspecific variation
between
C. glabrata strains. The phylogeny in Fig.
5B (ln
l =

1,079.341) was inferred by using maximum
likelihood method with
the F84 model, the transversion/transition ratio
was equal to
2.0, and strain CBS 138 was used as an outgroup. This
phylogeny
indicates that two groups of strains are present in our
sample.
Type 1 strains represent strains from the United States except
for the presence of two Brazilian strains,
C. glabrata 71 and
06. On the other hand, type 2 strains almost exclusively include
Brazilian strains with the exception of strain USA16. These data
suggest that these polymorphisms might be geographically related
and
that migration could be responsible for the inverse positions
of
strains 71, 06, and USA16.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 5.
Interspecific and intraspecific phylogenetic analysis of
COX2 genes of Candida glabrata and closely
related taxa. (A) Maximum likelihood tree for several fungi, rooted for
S. pombe and N. crassa, to compare the average
intraspecific distances of C. glabrata strains from their
closest relatives. (B) Maximum likelihood phylogeny of C. glabrata strains supporting the existence of two types with a
bootstrap value of 89% in 500 replications. The same topologies for
trees in panels A and B were observed when neighbor-joining algorithms
with HKY distances were used. The scale bars below the trees indicate
percent divergence, and the numbers above the tree nodes indicate the
percentage of that particular branch cluster in 500 bootstrap
replications. Species abbreviations are as follows: S-c, S. cerevisiae; S.e, S. exiguus; W.su, W. saturnus var. suaveolens; W.sa, W. saturnus
var. makrii; D.b, D. bruxellensis; K.l, K. lactis; K.t, K. thermotolerans; P.j, P. jadinii; C.g, C. glabrata; B.ci, B. custersii; N.c, N. crassa; Sc.p, S. pombe.
|
|
 |
DISCUSSION |
Typing of pathogenic yeasts is relevant for epidemiology because
it helps to identify sources of contamination, detect outbreaks in
hospital environments, and identify strains that are either more
virulent or more resistant to antifungal drugs. Typing is dependent on
the intraspecific variation in a species and is usually done by methods
that use comparative analyses of profiles, such as RAPD and RFLP
analyses. Despite their easy applicability, these methods are subjected
to several systematic errors due to the nonindependence of characters
(31). In the present work we tackled the problem of typing
intraspecific variants of C. glabrata by comparison of
COX2 sequences. A total of 16 of 756 (2.1%) positions were
variable in our sample, and 13 different haplotypes were identified.
Phylogenetic analysis of these data suggests that the 13 haplotypes can
be grouped into two types, types 1 and 2, which is supported by 89%
bootstrap replications. These two types are basically identified by
synonymous substitutions at positions 51 and 519. These polymorphic
positions could be correlated with the geographical origins of the
strains because 82% of Brazilian isolates belong to type 2 and 90% of
the U.S. isolates belong to type 1. The U.S. strains are more closely
related to the American Type Culture Collection strain used as a
reference and an internal control for sequencing. One explanation for
the two Brazilian strains that have a type 1 COX2 gene and
the U.S. strain that has a type 2 COX2 gene might be
relatively recent migratory events. However, it would be ideal for more
sequences to be studied to confirm or refute the expected hypothesis
suggested by our data regarding the association of type 1 COX2 with U.S. strains and type 2 COX2 with
Brazilian strains. None of the nonsynonymous changes affect the amino
acid residues that are essential for the correct structure and function
of the Cox2 peptide (Fig. 3) (13).
Strain CBS 138, whose sequence has been published previously,
represents the most distantly related isolate in the data set. It has a
C residue at position 51 and an A residue at position 52. This strain
also does not have the frameshift mutation at position 673 that we
observed in all other strains, including the American Type Culture
Collection control strain. The lack of this frameshift mutation is
observed in S. cerevisiae as well, which suggests that among
C. glabrata strains there might exist a group of strains
that are more closely related to S. cerevisiae and a group
of strains that are more distantly related and that contain the
frameshift mutation at position 673. Because we observed no alterations
in the phenotypes of our isolates growing in culture under aerobic
conditions, we conclude that the COX2 gene product of
strains that contain the frameshift mutation must be a functional peptide. This frameshift mutation without suppressor mechanisms would
originate a truncated protein without the copper binding domain which
encompasses two histidines and two cysteines in the carboxy-terminal
end (13). In fact, mitochondrial gene frameshift mutations
and corresponding suppressor mechanisms have already been described in
yeast mitochondria (11, 19, 28).
The amplification from total cellular DNA yields a fragment that
corresponds to the expressed copy of COX2 and not a nuclear pseudogene. Sequence divergence analyses that use mitochondrial DNA are
subject to this type of artifact, particularly when the mitochondrial
gene recently moved to the nucleus. To verify whether pseudogenes are
coamplified, it has been proposed that mitochondrial genes should be
amplified from poly(A)+ mRNA (5). Although the
level of DNA contamination in our mtRNA preparation is below the level
of detection, some nuclear gene-encoded mRNA is present, as seen for
the actin control (Fig. 1B, lane 3). Since nuclear pseudogenes do not
have corresponding transcripts, this assay readily enabled us to
control for this type of artifact.
We believe that the comparative sequence analysis of COX2
can be used to discriminate major subgroups of strains over broad geographic locations. Considering the evolutionary rate for
COX2 that we calculated on the basis of calibrations for 18S
ribosomal DNA, we estimate that the most closely related strains in our sample diverged approximately 5 × 105 years ago and
that the divergence between type 1 and type 2 strains occurred 1 × 106 years ago. Strain CBS 138 would have diverged 2 × 106 years ago. For typing of more closely related
isolates, we need to use even faster markers such as the intergenic
regions in the mitochondrial DNA. Nevertheless, the present work
represents the first example of the typing or the intraspecific
differentiation of pathogenic yeasts by direct comparison of a DNA
sequence, with additional assessment of results of polymorphism
analysis under a phylogenetically consistent probabilistic model.
 |
ACKNOWLEDGMENTS |
We thank David Perlin and Arnaldo L. Colombo for kindly providing
clinical isolates from the United States and Brazil and Sylvia
Leão, Nobuko Yoshida, and Sergio Schenkman for careful review of
the manuscript.
This work was supported by grants to M.R.S.B from Fundação
de Amparo à Pesquisa do Estado de São Paulo, FAPESP, of
Brazil. G.F.O.S. received a graduate fellowship from CNPq of Brazil.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Disciplina de
Microbiologia, Departamento de Microbiologia, Imunologia e
Parasitologia, Escola Paulista de Medicina, Universidade Federal de
São Paulo, Rua Botucatu, 862, 3° andar, CEP 04023-062, São Paulo, S.P., Brazil, Phone: (55) (11)5084-3213. Fax: (55)
(11)571-6504. E-mail: marcelo.dmip{at}epm.br.
 |
REFERENCES |
| 1.
|
Barns, S. M.,
D. J. Lane,
M. L. Sogin,
C. Bibeau, and W. G. Weisburg.
1991.
Evolutionary relationships among pathogenic Candida species and relatives.
J. Bacteriol.
173:2250-2255[Abstract/Free Full Text].
|
| 2.
|
Brown, W. M.,
E. M. Prager,
A. Wang, and A. C. Wilson.
1982.
Mitochondrial DNA sequences of primates: tempo and mode of evolution.
J. Mol. Evol.
18:225-239[CrossRef][Medline].
|
| 3.
|
Clark-Walker, G. D.
1991.
Contrasting mutation rates in mitochondrial and nuclear genes of yeasts versus mammals.
Curr. Genet.
20:195-198[CrossRef][Medline].
|
| 4.
|
Clark-Walker, G. D., and G. F. Weiller.
1994.
The structure of the small mitochondrial DNA of Kuyveromyces thermotolerans is likely to reflect ancestral gene order in fungi.
J. Mol. Evol.
38:593-601[Medline].
|
| 5.
|
Collura, R. V.,
M. R. Auerbach, and C.-B. Stewart.
1996.
A quick, direct method that can differentiate expressed mitochondrial genes from their nuclear pseudogenes.
Curr. Biol.
6:1337-1339[CrossRef][Medline].
|
| 6.
|
Defontaine, A.,
F. M. Lecocq, and J. N. Hallet.
1991.
A rapid miniprep for the preparation of yeast mitochondrial DNA.
Nucleic Acids Res.
19:185[Free Full Text].
|
| 7.
|
Escalante, A. A., and F. J. Ayala.
1995.
Evolutionary origin of Plasmodium and other Apicomplexa based on rRNA genes.
Proc. Natl. Acad. Sci. USA
92:5793-5797[Abstract/Free Full Text].
|
| 8.
|
Felsenstein, J.
1985.
Confidence limits on phylogenies: an approach using the bootstrap.
Evolution
39:783-791[CrossRef].
|
| 9.
|
Felsenstein, J.
1981.
Evolutionary trees from DNA sequences: a maximum likelihood approach.
J. Mol. Evol.
17:368-376[CrossRef][Medline].
|
| 10.
|
Fidel, P. L. J.,
J. A. Vazquez, and J. D. Sobel.
1999.
Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.
Clin. Microbiol. Rev.
12:80-96[Abstract/Free Full Text].
|
| 11.
|
Fox, T. D., and B. Weiss-Brummer.
1980.
Leaky +1 and 1 frameshift mutations at the same site in a yeast mitochondrial gene.
Nature
288:60-63[CrossRef][Medline].
|
| 12.
|
Galtier, N.,
M. Gouy, and C. Gautier.
1996.
SEAVIEW and PHYLO_WIN: two graphic tools for sequence alignment and molecular phylogeny.
Comput. Appl. Biosci.
12:543-548[Abstract/Free Full Text].
|
| 13.
|
Hatefi, Y.
1985.
The mitochondrial electron transport and oxidative phosphorylation system.
Annu. Rev. Biochem
54:1015-1069[CrossRef][Medline].
|
| 14.
|
Hazen, K. C.
1995.
New and emerging yeast pathogens.
Clin. Microbiol. Rev.
8:462-478[Abstract].
|
| 15.
|
Helmerhorst, E. J.,
I. M. Reijnders,
W. van't Hof,
I. Simoons-Smit,
E. C. Veerman, and A. V. Amerongen.
1999.
Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides.
Antimicrob. Agents Chemother.
43:702-704[Abstract/Free Full Text].
|
| 16.
|
Higgins, D. G.,
A. J. Bleasby, and R. Fuchs.
1991.
CLUSTAL V: improved software for multiple sequence alignment.
Comput. Appl. Biosci.
8:189-191[Abstract/Free Full Text].
|
| 17.
|
Hillis, D. M.,
J. P. Huelsenbeck, and C. W. Cunningham.
1994.
Application and accuracy of molecular phylogenies.
Science
264:671-677[Abstract/Free Full Text].
|
| 18.
|
Hopfer, R. L.,
P. Walden,
S. Setterquist, and W. E. Highsmith.
1993.
Detection and differentiation of fungi in clinical specimens using polymerase chain reaction (PCR) amplification and restriction enzyme analysis.
J. Med. Vet. Mycol.
31:65-76[Medline].
|
| 19.
|
Hüttenhofer, A.,
B. Weiss-Brummer,
G. Dirheimer, and R. P. Martin.
1990.
A novel type of +1 frameshift suppressor: a base substitution in the anticodon stem of a yeast mitochondrial serine-tRNA causes frameshift suppression.
EMBO J.
9:551-558[Medline].
|
| 20.
|
Li, W. H., and D. Graur.
1991.
Fundamentals of molecular evolution.
Sinauer Associates, Sunderland, Mass.
|
| 21.
|
Maidak, B. L.,
J. R. Cole,
C. T. Parker, Jr.,
G. M. Garrity,
N. Larsen,
B. Li,
T. G. Lilburn,
M. J. McCaughey,
G. J. Olsen,
R. Overbeek,
Sakti Pramanik,
T. M. Schmidt,
J. M. Tiedje, and C. R. Woese.
1999.
A new version of the RDP (Ribosomal Database Project).
Nucleic Acids Res.
27:171-173[Abstract/Free Full Text].
|
| 22.
|
Marchuk, D.,
M. Drumm,
A. Saulino, and F. S. Collins.
1990.
Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products.
Nucleic Acids Res.
19:1154[Free Full Text].
|
| 23.
|
Melo, A. S. A.,
L. P. Almeida,
A. L. Colombo, and M. R. S. Briones.
1998.
Evolutionary distances and identification of Candida species in clinical isolates by randomly amplified polymorphic DNA (RAPD).
Mycopathologia
142:57-66[CrossRef][Medline].
|
| 24.
|
Miyazaki, H.,
Y. Miyazaki,
A. Geber,
T. Parkinson,
C. Hitchcock,
D. J. Falconer,
D. J. Ward,
K. Marsden, and J. E. Bennett.
1998.
Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PHD1, in Candida glabrata.
Antimicrob. Agents Chemother.
42:1695-1701[Abstract/Free Full Text].
|
| 25.
|
Pfaller, M. A., and A. L. Barry.
1995.
In vitro susceptibilities of clinical isolates to three antifungal agents determined by the microdilution method.
Mycopathologia
130:3-9[CrossRef][Medline].
|
| 26.
|
Power, E. G. M.
1996.
RAPD typing in microbiology a technical review.
J. Hosp. Infect.
34:247-265[CrossRef][Medline].
|
| 27.
|
Saitou, N., and M. Nei.
1987.
The neighbor-joining method: a new method for reconstructing phylogenetic trees.
Mol. Biol. Evol.
4:406-425[Abstract].
|
| 28.
|
Sakai, H.,
R. Stiess, and B. Weiss-Brummer.
1991.
Mitochondrial mutations restricting spontaneous translational frameshift suppression in the yeast Saccharomyces cerevisiae.
Mol. Gen. Genet.
227:306-317[Medline].
|
| 29.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 30.
|
Sanger, F.,
S. Nicklen, and A. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 31.
|
Swofford, D. L.,
G. J. Olsen,
P. J. Waddell, and D. M. Hillis.
1996.
Phylogenetic inference, p. 407-514.
In
D. M. Hillis, C. Moritz, and B. K. Mable (ed.), Molecular systematics. Sinauer Associates, Sunderland, Mass.
|
| 32.
|
Wach, A.,
H. Pick, and P. Philippsen.
1994.
Procedures for isolating yeast DNA for different purposes.
In
J. R. Johnston (ed.), Molecular genetics of yeast. IRL Press at Oxford University Press, Oxford, United Kingdom.
|
| 33.
|
Woese, C. R.
1987.
Bacterial evolution.
Microbiol. Rev.
51:221-271[Free Full Text].
|
| 34.
|
Zuckerkandl, E., and L. Pauling.
1962.
Molecular disease, evolution and genetic heterogeneity, p. 189-225.
In
M. Marsha, and B. Pullman (ed.), Horizons in biochemistry. Academic Press, Inc., New York, N.Y.
|
Journal of Clinical Microbiology, January 2000, p. 227-235, Vol. 38, No. 1
0095-1137/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Foulet, F., Nicolas, N., Eloy, O., Botterel, F., Gantier, J.-C., Costa, J.-M., Bretagne, S.
(2005). Microsatellite Marker Analysis as a Typing System for Candida glabrata. J. Clin. Microbiol.
43: 4574-4579
[Abstract]
[Full Text]
-
Dodgson, A. R., Pujol, C., Denning, D. W., Soll, D. R., Fox, A. J.
(2003). Multilocus Sequence Typing of Candida glabrata Reveals Geographically Enriched Clades. J. Clin. Microbiol.
41: 5709-5717
[Abstract]
[Full Text]
-
Boldo, X. M., Villa-Tanaca, L., Zuniga, G., Hernandez-Rodriguez, C.
(2003). Genetic Diversity among Clinical Isolates of Candida glabrata Analyzed by Randomly Amplified Polymorphic DNA and Multilocus Enzyme Electrophoresis Analyses. J. Clin. Microbiol.
41: 4799-4804
[Abstract]
[Full Text]
-
Langkjaer, R. B., Casaregola, S., Ussery, D. W., Gaillardin, C., Piskur, J.
(2003). Sequence analysis of three mitochondrial DNA molecules reveals interesting differences among Saccharomyces yeasts. Nucleic Acids Res
31: 3081-3091
[Abstract]
[Full Text]
-
de Meeus, T., Renaud, F., Mouveroux, E., Reynes, J., Galeazzi, G., Mallie, M., Bastide, J. M.
(2002). Genetic Structure of Candida glabrata Populations in AIDS and Non-AIDS Patients. J. Clin. Microbiol.
40: 2199-2206
[Abstract]
[Full Text]
-
Yokoyama, K., Biswas, S. K., Miyaji, M., Nishimura, K.
(2000). Identification and Phylogenetic Relationship of the Most Common Pathogenic Candida Species Inferred from Mitochondrial Cytochrome b Gene Sequences. J. Clin. Microbiol.
38: 4503-4510
[Abstract]
[Full Text]